Skip to the page

Data / Form D filings / Flagship Biosciences, Inc.

Flagship Biosciences, Inc.: Form D filings

Flagship Biosciences, Inc., a biotechnology company in Broomfield, CO, filed 6 Form D notices with the SEC between 2018 and 2024. The latest, on April 18, 2024, reports $5 million sold of a $6.4 million offering to 3 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
11800 RIDGE PARKWAY, SUITE 450, Broomfield, CO, 80021
Phone
(303) 325-5894
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1733718

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 18, 2024New notice$6,369,795$5,000,000$1,369,7953Apr 10, 2024sec.gov
Feb 21, 2024Amendment$5,000,000$3,000,000$2,000,0003Nov 27, 2023sec.gov
Dec 14, 2023New notice$1,500,000$1,500,0003Nov 27, 2023sec.gov
Sep 9, 2022New notice$15,285,339$15,285,3393Aug 19, 2022sec.gov
Jul 9, 2018New notice$2,500,000$2,500,00010Jun 26, 2018sec.gov
Mar 16, 2018New notice$1,000,000$1,000,0009Jan 9, 2018sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Paul KirchgraberDirector
Trevor JohnsonExecutive Officer, Director
Tom TuriExecutive Officer, Director
Herb HooperDirector
William SniderDirector

Other biotechnology companies in Colorado that filed recently

Every Form D from the week of Apr 15, 2024 · All recent filings in Colorado · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Flagship Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.